| Welcome and introduction |
| Genetic Predisposition Syndromes In Myeloid Malignancies Lecture: Lucy Godley |
|
Session 1: Germline Predisposition Syndromes Thursday, 8:40 - 10:35 am
|
|
SH2017-0283
|
Dr. Rena Xian
|
Familial AML with germline CEBPA mutation
|
|
SH2017-0039
|
Dr. Karen Chisholm
|
MDS arising in a 13-year-old with RUNX1 familial platelet disorder
|
|
SH2017-0307
|
Dr. Chollada Curry
|
Relapsed pediatric myelodysplastic syndrome with a germline GATA2 heterozygous deletion, monosomy 7, and somatic CRLF2 mutation
|
|
SH2017-0042
|
Dr. Craig Soderquist
|
Myeloproliferative disorder, ET-like, associated with germline SH2B3 mutation
|
|
SH2017-0106
|
Dr. Sunita Park
|
Familial Burkitt lymphoma reveals X-linked lymphoproliferative disease (XLP)
|
|
SH2017-0167
|
Dr. Chelsey Part |
Therapy-related Acute Myeloid Leukemia in a Patient with Li-Fraumeni Syndrome |
|
SH2017-0275
|
Dr. Cecilia Young
|
Mild Megakaryocyte Atypia in a Patient with Presumed Germline GATA2 Mutation, and Disseminated Mycobacterial Infection.
|
| Session 1 Summary - Olga Weinberg |
|
Fundamentals of Next Generation Sequencing: Technologies and Applications Lecture: Eric Duncavage
|
|
Molecular Genetics of Small Mature B-Cell Lymphomas Lecture: Elias Campo
|
| Seattle Genetics Lunch Symposium: Lymphoma Pathogenesis as the Ultimate Diagnostic and Therapeutic Guidance |
|
Session 2: Genetic Testing in Diagnosis of Lymphoid Neoplasms Thursday, 1:30 - 3:25 pm
|
|
SH2017-0160
|
Dr. Todd. Williams
|
Entire exome sequencing or high grade B cell lymphoma with BCL2 / MYC rearrangements reveals actionable mutations and antecedent follicular lymphoma
|
|
SH2017-0137
|
Dr. Katrin Huettl
|
An Aggressive Burkitt-Like Lymphoma With 11q Aberration
|
|
SH2017-0341
|
Dr. Nidhi Aggarwal
|
Large B-cell lymphoma with IRF4 rearrangement in a 63-year-old male
|
|
SH2017-0334
|
Dr. Pallavi Khattar |
t (14:18) negative follicular lymphoma (FL) with 1p36 deletion associated with in situ follicular neoplasia (ISFN) with t (14:18) translocation.
|
|
SH2017-0111
|
Dr. David Wu
|
STAT3 mutated T-LGL, donor derived, post-cord transplant for T lymphoblastic leukemia
|
|
SH2017-0277
|
Dr. Caleb Ho
|
Comprehensive Molecular Profiling of an ALK Negative, Anaplastic Large Cell Lymphoma with DUSP22 rearrangement
|
|
SH2017-0377
|
Dr. Philippe Gaulard
|
Clonal evolution of a TET2 mutated-angioimmunoblastic T-cell lymphoma towards an EBV-associated TFH PTCL
|
| Session 2 Summary |
|
Fundamentals of Next-Generation Sequencing: Analysis and Interpretation Lecture: Frank Kuo
|
|
Session3: Genetic Testing in Diagnosis of Acute Leukemias Thursday, 4:15 - 6:10 pm
|
|
SH2017-0180
|
Dr. Keyur Patel
|
Acute Myeloid Leukemia (Promyelocytic), with Novel IRF2BP2-RARA Fusion
|
|
SH2017-0281
|
Dr. James Bauer
|
Acute myeloid leukemia with RUNX1 and several co-mutations
|
|
SH2017-0299
|
Dr. Ashley Bird
|
De novo acute myeloid leukemia with BCR-ABL1
|
|
SH2017-0328
|
Dr. Kenneth Holder
|
Therapy-related acute myeloid leukemia with monocytic differentiation and MLL gene rearrangement after treatment for acute promyelocytic leukemia
|
|
SH2017-0108
|
Dr. Emily Mason
|
B lymphoblastic leukemia arising in a patient with a history of lymphoplasmacytic lymphoma
|
|
SH2017-0366
|
Dr. Marian Harris
|
Pediatric B-ALL with iAMP21
|
|
SH2017-0343
|
Dr. Sarah Ondrejka
|
Ph-like B-lymphoblastic leukemia, with a kinase-activating alteration
|
| Session 3 Summary |
|
Clinical Significance of Somatic Mutations in Hematologic Neoplasia Lecture: Benjamin Ebert
|
|
Session 4: Genetic Testing in Diagnosis or Myeloid Neoplasms (Excluding Acute Leukemia) Friday, 8:30 - 10:25 am
|
|
SH2017-0124
|
Dr. John Goodlad
|
A case of persistent neutrophilia: BCR-ABL negative
|
|
SH2017-0351
|
Dr. Madhu Menon
|
Chronic myelomonocytic leukemia with molecular abnormalities
|
|
SH2017-0156
|
Dr. Jeffrey Craig
|
Unmasking or Multiorgan Involvement by Systemic Mastocytosis
|
|
SH2017-0171
|
Dr. Shunyou Gong
|
Juvenile myelomonocytic leukemia with competitor somatic KRAS and PTPN11 Mutations in A Child Harboring Germline ASXL1 Mutation
|
|
SH2017-0376
|
Dr. Magdalena Czader
|
Myeloid neoplasm with PCM1-JAK2 presenting with hepatosplenomegaly
|
|
SH2017-0300
|
Dr. Geetha Jagannathan
|
Chronic Eosinophilic Leukemia, NOS Diagnosed by Next Generation Sequencing
|
|
SH2017-0314
|
Dr. Habibe Kurt
|
Blastic Plasmacytoid Dendritic Cell Neoplasm with TET2 and DNMT3A mutations
|
| Session 4 Summary |
|
Session 5: Pre-Malignant Clonal Proliferations Friday, 10:45 am - 12:30 pm
|
|
SH2017-0269
|
Dr. Adam Wood
|
Probable early myelodysplastic syndrome
|
|
SH2017-0050
|
Dr. Mary-Ann Thompson Arildsen
|
Pancytopenia in a 38-year-old male: ICUS to CCUS to MDS
|
|
SH2017-0350
|
Dr. Vignesh Shanmugam
|
Clonal Cytopenia or Undetermined Significance Progressing to ASXL1 and SF3B1 -mutated CMML-1 with Ring Sideroblasts
|
|
SH2017-0028
|
Dr. Anwar Rjoop |
Incidental myeloid sarcoma diagnosed in a patient with ASXL1 + lymphoplasmytic lymphoma |
|
SH2017-0256
|
Dr. Saham Loghavi |
Incidental MYD88 p.L265P Mutation: a Clue to Competitor B-Cell Lymphoma in a Patient with Chronic Myelomonocytic Leukemia
|
|
SH2017-0332
|
Dr. Lena Stuart
|
TP53 mutation in a patient with paroxysmal nocturnal hemoglobinuria
|
| Session 5 Summary |
| Archer Diagnostics Lunch Symposium |
|
Session 6: Genetics Revealing the Biology of Myeloid Neoplasms (Excluding Acute Leukemias) Friday, 3:20 - 5:05 pm
|
|
SH2017-0068
|
Dr. Yahya Al-Ghamdi
|
46 year old male with CML in blast crisis with t (15; 17) and RARA gene rearrangement
|
|
SH2017-0244
|
Dr. Pawel Mroz
|
Myelodysplastic syndrome (MDS) associated with primary mediastinal germ cell tumor
|
|
SH2017-0267
|
Dr. Larissa Liontos
|
Myeloid neoplasm with morphological features of atypical CML and NPM1 mutation
|
|
SH2017-0207
|
Dr. Anna Nam
|
Progression of a JAK2 V617F-Positive Essential Thrombocythemia (ET) to a JAK2- V617F-Negative Post-ET Myelofibrosis in Accelerated Phase
|
|
SH2017-0238
|
Dr. Leonardo Boiocchi
|
Unexpected detection of SF3B1 mutation and ring pageoblasts in a JAK2 + pure myeloproliferative neoplasm
|
|
SH2017-0159
|
Dr. Natasha Lewis
|
Myeloid neoplasm with del (5q) and SF3B1 and MPL gene mutations
|
| Session 6 Summary |
|
Therapy-Related Myeloid Neoplasms: When Genetics and Environment Collide Lecture: Megan McNerney
|
|
Session 7: Genetics Revealing the Biology of Acute Leukemias Saturday, 8:30 - 10:15 am
|
|
SH2017-0057
|
Dr. Jason Aynardi
|
Acute Myeloid Leukemia with JAK2 V617F Mutation
|
|
SH2017-0094
|
Dr. Jessica Snider |
NUP214-ABL1 fusion: A novel discovery in acute myelomonocytic leukemia
|
|
SH2017-0144
|
Dr. Siddharth Bhattacharyya
|
Differentiated response to FLT3 inhibition (Quizartinib / AC220) in acute myeloid leukemia is affected by baseline molecular genetics and cytogenetics
|
|
SH2017-0119
|
Dr. Sarah Choi
|
A 22-year-old male with a Ph-like mixed phenotype acute leukemia (B / myeloid)
|
|
SH2017-0148
|
Dr. Madhu Ouseph |
AML with myelodysplasia-related changes and cryptic t (8; 16) (p11; p13); KAT6A / CREBBP
|
|
SH2017-0203
|
Dr. Rebecca Leeman-Neill
|
Acute leukemia or ambiguous lineage in a pediatric patient with a NUP98-NSD1 rearrangement
|
| Session 7 Summary |
|
Novel Insights into the Molecular Pathogenesis of T-cell Lymphomas Lecture: Kojo Elenitoba-Johnson
|
|
Session 8: Genetics Revealing the Biology of Lymphoid Neoplasms Saturday, 11:05 am - 12:50 pm
|
|
SH2017-0086
|
Dr. Leticia Quintanilla-Fend
|
Leukemic non-nodal MCL with complex karyotype and TP53 deletion and mutation with rather indolent clinical behavior.
|
|
SH2017-0327
|
Dr. Rohit Gulati
|
Leukemic non-nodal MCL with complex karyotype and TP53 deletion and mutation with rather indolent clinical behavior
|
|
SH2017-0338
|
Dr. Andrew Evans |
IGH sequencing distinguishes multiple EBV + mucocutaneous ulcers from recurrent malignant diffuse large B cell lymphoma
|
|
SH2017-0359
|
Dr. Shiraz Fidai |
Progression of CLL with two Richter transformations associated with two different MYC rearrangements
|
|
SH2017-0210
|
Dr. Jonathon Gralewski
|
Myeloid Sarcoma with Monocytic Differentiation and IGH-MAF Gene Reaction
|
|
SH2017-0035
|
Dr. Mariusz Wasik
|
Mantle cell lymphoma trans-differentiated into poorly differentiated sarcoma with evidence of muscle and neutral differentiation
|
| Session 8 Summary |
| Wrokshop Concluding remarks |
EDUCATION
-->